Skip to main content
Premium Trial:

Request an Annual Quote

Incaps Inks Deal to Provide Informatics to BASi Customers

NEW YORK, Feb. 16 (GenomeWeb News) - Incaps and Bioanalytical Systems have signed an alliance to provide complementary services to clients, BASi announced today.


Under the deal, BASi will rely on INCAPS to service clients' needs for instrumentation, informatics, and statistical analysis, the company said.


The partnership will mean "one-stop shopping for large and small-molecule work," said Incaps CEO James Ludwig.


Financial details were not provided.


BASi is a drug-to-market contract research company located in West Lafayette, In.


Incaps, which offers protein analysis, proteomics, technology validation and biomarker collaboration, is located in Indianapolis.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.